NIH Licenses Coronavirus Research Tools To WHO

President Joe Biden said Thursday (May 12) the United States licensed coronavirus medical technologies, including the stabilized spike protein, for WHO’s COVID-19 Technology Access Pool to use. Most covid vaccines depend on the National Institutes of Health’s spike protein technology, according to Public Citizen, which praised the announcement. “The announcement is a turn toward sharing not only doses, but knowledge, which is the difference between charity and justice,” Public Citizen Access to Medicines Director Peter Maybarduk said, though he criticized...
Article Type: 
Site Name: 
InsideHealthPolicy.com
IDP Issue: 
Inside Drug Pricing - 05/16/2022
IDP Volume: 
Vol. 5, No. 20
Author: 

NAIC To Congress: Let Us Oversee MA Marketing

State insurance commissioners are asking Congress to amend federal law that gave CMS authority to regulate the marketing of Medicare Advantage plans and hand that power to the states, which, they argue, are better equipped to conduct needed oversight. “[A]s state insurance regulators, we are finding an increase in complaints from seniors about confusing, misleading, and potentially deceptive advertising and marketing of these plans,” the National Association of Insurance Commissioners (NAIC) wrote in a May 5 letter to House and...
Article Type: 
Tags: 
Site Name: 
InsideHealthPolicy.com
CMS Issue: 
Inside CMS - 05/19/2022
CMS Volume: 
Vol. 25, No. 20
HEA Issue: 
Health Exchange Alert Weekly Report - 05/18/2022
HEA Volume: 
Vol. 10, No. 20
Author: 

E&C Panel Clears Eshoo’s Bill That Would Place ARPA-H Within HHS

The House Energy & Commerce health subcommittee on Wednesday (May 11) passed by voice vote subcommittee Chair Anna Eshoo’s (D-CA) bill that would make the newly authorized Advanced Research Projects Agency for Health an independent agency within HHS, seemingly overriding HHS’ recent decision to put ARPA-H under the National Institutes of Health. Eshoo and other lawmakers also said they’ll work to ensure the agency is physically separate from NIH and HHS and headquartered outside of Washington, D.C. The bill could...
Article Type: 
Tags: 
Site Name: 
InsideHealthPolicy.com
FDA Issue: 
FDA Week - 05/13/2022
FDA Volume: 
Vol. 28, No. 19
Author: 












Pages

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.